These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29368847)

  • 1. Pyoderma gangrenosum, acne, hidradenitis suppurativa syndrome associated with type 1 diabetes mellitus treated with adalimumab.
    Fattore D; Pistone G; Bongiorno MR
    G Ital Dermatol Venereol; 2019 Apr; 154(2):218-220. PubMed ID: 29368847
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis.
    Murphy B; Morrison G; Podmore P
    Int J Colorectal Dis; 2015 Aug; 30(8):1139-40. PubMed ID: 25564349
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyoderma gangrenosum, acne, and suppurative hidradenitis syndrome in end-stage renal disease successfully treated with adalimumab.
    De Wet J; Jordaan HF; Kannenberg SM; Tod B; Glanzmann B; Visser WI
    Dermatol Online J; 2017 Dec; 23(12):. PubMed ID: 29447652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyoderma gangrenosum associated with cystic acne and hidradenitis suppurativa controlled by adding minocycline and sulfasalazine to the treatment regimen.
    Shenefelt PD
    Cutis; 1996 May; 57(5):315-9. PubMed ID: 8726710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Necrosis Factor Antagonists in the Treatment of Pyoderma Gangrenosum, Acne, and Suppurative Hidradenitis (PASH) Syndrome.
    Saint-Georges V; Peternel S; Kaštelan M; Brajac I
    Acta Dermatovenerol Croat; 2018 Jun; 26(2):173-178. PubMed ID: 29989876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne.
    Vinkel C; Thomsen SF
    Int J Dermatol; 2017 Aug; 56(8):811-818. PubMed ID: 28345207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum, acne conglobata, suppurative hidradenitis, and axial spondyloarthritis: efficacy of anti-tumor necrosis factor α therapy.
    Bruzzese V
    J Clin Rheumatol; 2012 Dec; 18(8):413-5. PubMed ID: 23188209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyoderma Gangrenosum, Acne and Suppurative Hidradenitis Syndrome Treated with Granulocyte and Monocyte Adsorption Apheresis.
    Mizutani Y; Okano T; Takahashi T; Ohnishi H; Ohara O; Sano A; Seishima M
    Acta Derm Venereol; 2017 Feb; 97(2):275-276. PubMed ID: 27384061
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) with weight-based anakinra dosing in a Hepatitis B carrier.
    Jennings L; Molloy O; Quinlan C; Kelly G; O'Kane M
    Int J Dermatol; 2017 Jun; 56(6):e128-e129. PubMed ID: 28239847
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term Remission of Pyoderma Gangrenosum, Acne, and Hidradenitis Suppurativa Syndrome.
    Brokamp G; Bechtel M; Chung C
    Cutis; 2023 Jun; 111(6):E2-E6. PubMed ID: 37487120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients.
    Join-Lambert O; Duchatelet S; Delage M; Miskinyte S; Coignard H; Lemarchand N; Alemy-Carreau M; Lortholary O; Nassif X; Hovnanian A; Nassif A
    J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S66-9. PubMed ID: 26470620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition.
    Saraceno R; Babino G; Chiricozzi A; Zangrilli A; Chimenti S
    J Am Acad Dermatol; 2015 Jan; 72(1):e42-4. PubMed ID: 25497954
    [No Abstract]   [Full Text] [Related]  

  • 13. Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes?
    Garzorz N; Papanagiotou V; Atenhan A; Andres C; Eyerich S; Eyerich K; Ring J; Brockow K
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):141-3. PubMed ID: 25070077
    [No Abstract]   [Full Text] [Related]  

  • 14. Novel PSTPIP1 gene mutation in pyoderma gangrenosum, acne and suppurative hidradenitis syndrome.
    Saito N; Minami-Hori M; Nagahata H; Nozaki H; Iinuma S; Igawa S; Kanno K; Kishibe M; Kanazawa N; Ishida-Yamamoto A
    J Dermatol; 2018 Aug; 45(8):e213-e214. PubMed ID: 29575118
    [No Abstract]   [Full Text] [Related]  

  • 15. Remission of Refractory PASH Syndrome Using Ixekizumab and Doxycycline.
    Gul MI; Singam V; Hanson C; Neill BC; Aires DJ; Rajpara AN
    J Drugs Dermatol; 2020 Nov; 19(11):1123. PubMed ID: 33196740
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone.
    Staub J; Pfannschmidt N; Strohal R; Braun-Falco M; Lohse P; Goerdt S; Leverkus M
    J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2243-7. PubMed ID: 25352307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tildrakizumab in the treatment of PASH syndrome: A potential novel therapeutic target.
    Kok Y; Nicolopoulos J; Varigos G; Howard A; Dolianitis C
    Australas J Dermatol; 2020 Aug; 61(3):e373-e374. PubMed ID: 32285437
    [No Abstract]   [Full Text] [Related]  

  • 18. Pyoderma gangrenosum, acne, suppurative hidradenitis (PASH) and polycystic ovary syndrome: Coincidentally or aetiologically connected?
    Zivanovic D; Masirevic I; Ruzicka T; Braun-Falco M; Nikolic M
    Australas J Dermatol; 2017 May; 58(2):e54-e59. PubMed ID: 26831949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secukinumab for PASS syndrome: A new choice for therapeutic challenge?
    Li M; Xiang H; Liang Y; Xue L; Zhou X; Yang L; Liu H; Yang M; Tang J; Li W
    Dermatol Ther; 2022 Jul; 35(7):e15507. PubMed ID: 35419914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of PASS syndrome with IVIG and anti-IL-1 treatment: A case report.
    Kırmızıer G; Kılınç EA; Yıldırım NO; Türsen Ü
    Int J Rheum Dis; 2024 Mar; 27(3):e15114. PubMed ID: 38465508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.